Dr. Reddy's
RDY
$69.65
Share price
-0.03%
Change (1 day)
25.95%
Change (1 year)
Categories
Dr. Reddy's (RDY) - P/B ratio
P/B ratio as of May 2024 : 3.67
According to Dr. Reddy's's latest financial reports the company has a price-to-book ratio of 3.67.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Dr. Reddy's - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.63 | 12.3% |
| 2022-12-31 | 3.23 | -24.69% |
| 2021-12-31 | 4.29 | -15.54% |
| 2020-12-31 | 5.08 | 58.75% |
| 2019-12-31 | 3.20 | -0.02% |
| 2018-12-31 | 3.20 | -0.91% |
| 2017-12-31 | 3.23 | -22.95% |
| 2016-12-31 | 4.19 | 1.84% |
| 2015-12-31 | 4.11 | -21.78% |
| 2014-12-31 | 5.26 | 3.95% |
| 2013-12-31 | 5.06 | 8.79% |
| 2012-12-31 | 4.65 | -9.69% |
| 2011-12-31 | 5.15 | -11.84% |
| 2010-12-31 | 5.84 | 22.8% |
| 2009-12-31 | 4.75 | 215.25% |
| 2008-12-31 | 1.51 | -43.4% |
| 2007-12-31 | 2.66 | -23.93% |
| 2006-12-31 | 3.50 | 5.9% |
| 2005-12-31 | 3.31 | -0.41% |
| 2004-12-31 | 3.32 | -37.28% |
| 2003-12-31 | 5.30 | -21.78% |
| 2002-12-31 | 6.77 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 5.30 | 44.49% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.83 | -50.01% | 🇺🇸 USA |
 Sanofi SNY | 1.53 | -58.26% | 🇫🇷 France |
 GlaxoSmithKline GSK | 5.59 | 52.54% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 2.34 | -36.21% | 🇮🇱 Israel |